A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. 1991

G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
Kabi Pharmacia Therapeutics AB, Lund, Sweden.

Binding of staphylococcal enterotoxin A (SEA) to MHC class II encoded proteins is a prerequisite for its subsequent activation of a large fraction of T lymphocytes through interaction with variable segments of the TCR-beta chain. We cloned SEA in Escherichia coli and produced four recombinant fragments covering both the N- and C-terminal regions. These fragments were used to analyze the interaction between SEA and the human MHC class II products. A C-terminal fragment of SEA, representing amino acids 107-233 bound to HLA-DR and HLA-DP but did not activate T cells. The three other fragments (amino acids 1-125, 1-179 and 126-233) neither bound to MHC class II Ag nor activated T cells. SEA apparently bind to HLA-DR and HLA-DP through its C-terminal part, whereas T cell activation is dependent on additional parts of the protein.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
March 1998, Journal of immunology (Baltimore, Md. : 1950),
G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
April 1991, Journal of immunology (Baltimore, Md. : 1950),
G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
May 1992, Cellular immunology,
G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
December 1999, Journal of immunology (Baltimore, Md. : 1950),
G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
January 1997, Advances in experimental medicine and biology,
G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
January 2011, PloS one,
G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
February 2010, Neurobiology of disease,
G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
April 1988, Journal of immunology (Baltimore, Md. : 1950),
G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
May 1996, Archives of dermatological research,
G Hedlund, and M Dohlsten, and T Herrmann, and G Buell, and P A Lando, and S Segrén, and J Schrimsher, and H R MacDonald, and H O Sjögren, and T Kalland
November 1990, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!